supported by the National Natural Science Foundation of China,No.81971177(to YK);the Natural Science Foundation of Beijing,No.7222198(to NH);the Peking University People's Hospital Research and Development Fund,No.RDX2021-01(to YK)。
FK506(Tacrolimus)is a systemic immunosuppressant approved by the U.S.Food and Drug Administration.FK506 has been shown to promote peripheral nerve regeneration,however,its precise mechanism of action and its pathways ...
Funded by National Center for Gene Therapy and Drugs Based on RNA Technology MUR-CN3 CUP E63C22000940007.
Scaffold proteins are crucial regulators of signaling networks,and their abnormal expression may favor the development of tumors.Among the scaffold proteins,immunophilin covers a unique role as‘protein-philin’(Greek...
supported by the National Natural Science Foundation of China (Nos. 81970903 and 81920108012);Fundamental Research Funds for the Central Universities,Jilin Provincial Science & Technology Department (No. 20200201527JC);Jilin Department of Health (No. 2019Q013);Department of Finance of Jilin Province (No. JCSZ2019378-6)。
Although bone morphogenetic protein(BMP) and WNT signaling play pivotal roles in bone development,homeostasis, and regeneration, the applications of proteins to stimulate corresponding signaling pathways showed limite...
Efficacious therapeutics for peripheral nerve injuries remain incompletely described in the literature.However,over the last several decades,delivery of FK506(Tacrolimus)and electrostimulation have demonstrated great ...